Covered recipient · General Payments record
MISBAH M VAHIDY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,706.85
- Reported across 239 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $735.15 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $246.68 | 30 |
| Phathom Pharmaceuticals, Inc. | $110.33 | 4 |
| Ardelyx, Inc. | $92.18 | 5 |
| Novo Nordisk AS | $87.09 | 5 |
| GlaxoSmithKline, LLC. | $74.88 | 4 |
| Lilly USA, LLC | $42.62 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $26.15 | 1 |
| ITI, Inc. | $21.96 | 1 |
| OptiNose US, Inc. | $19.60 | 1 |
| PFIZER INC. | $13.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.42 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264386 | CMS |
| ABBVIE INC. | $16.05 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264388 | CMS |
| ABBVIE INC. | $5.99 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264390 | CMS |
| ABBVIE INC. | $4.99 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264392 | CMS |
| ABBVIE INC. | $5.86 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264394 | CMS |
| ABBVIE INC. | $10.56 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264396 | CMS |
| ABBVIE INC. | $4.33 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264398 | CMS |
| ABBVIE INC. | $10.04 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264400 | CMS |
| ABBVIE INC. | $10.03 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264402 | CMS |
| ABBVIE INC. | $7.00 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264404 | CMS |
| ABBVIE INC. | $4.66 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264406 | CMS |
| ABBVIE INC. | $4.56 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264408 | CMS |
| ABBVIE INC. | $6.08 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264410 | CMS |
| ABBVIE INC. | $6.42 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264412 | CMS |
| ABBVIE INC. | $7.31 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264414 | CMS |
| ABBVIE INC. | $4.66 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264416 | CMS |
| ABBVIE INC. | $4.82 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264418 | CMS |
| ABBVIE INC. | $18.76 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264420 | CMS |
| ABBVIE INC. | $5.97 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264422 | CMS |
| ABBVIE INC. | $30.83 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264424 | CMS |
| ABBVIE INC. | $7.01 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264426 | CMS |
| ABBVIE INC. | $9.17 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264428 | CMS |
| ABBVIE INC. | $6.50 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264430 | CMS |
| ABBVIE INC. | $7.34 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264432 | CMS |
| ABBVIE INC. | $11.25 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264434 | CMS |
| ABBVIE INC. | $3.66 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264436 | CMS |
| ABBVIE INC. | $8.25 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264438 | CMS |
| ABBVIE INC. | $6.43 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264440 | CMS |
| ABBVIE INC. | $5.95 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264442 | CMS |
| ABBVIE INC. | $5.78 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106264444 | CMS |
| Ardelyx, Inc. | $21.47 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146712257 | CMS |
| Ardelyx, Inc. | $19.74 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146712259 | CMS |
| Ardelyx, Inc. | $19.94 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146712261 | CMS |
| Ardelyx, Inc. | $15.33 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146712263 | CMS |
| Ardelyx, Inc. | $15.70 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146712265 | CMS |
| GlaxoSmithKline, LLC. | $16.86 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116672408 | CMS |
| GlaxoSmithKline, LLC. | $16.15 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116564068 | CMS |
| GlaxoSmithKline, LLC. | $23.47 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116454035 | CMS |
| GlaxoSmithKline, LLC. | $18.40 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116388326 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $26.15 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153720414 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.96 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143336864 | CMS |
| Lilly USA, LLC | $18.62 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135238441 | CMS |
| Lilly USA, LLC | $24.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135258284 | CMS |
| Novo Nordisk Inc | $19.60 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097473430 | CMS |
| Novo Nordisk Inc | $15.47 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096755779 | CMS |
| Novo Nordisk Inc | $18.82 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097395456 | CMS |
| Novo Nordisk Inc | $14.88 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097535293 | CMS |
| Novo Nordisk Inc | $18.32 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599433 | CMS |
| Optinose US, Inc. | $19.60 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142189450 | CMS |
| PFIZER INC. | $13.66 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131440917 | CMS |
| Phathom Pharmaceuticals, Inc. | $30.02 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151135304 | CMS |
| Phathom Pharmaceuticals, Inc. | $26.37 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151135306 | CMS |
| Phathom Pharmaceuticals, Inc. | $31.71 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151135308 | CMS |
| Phathom Pharmaceuticals, Inc. | $22.23 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151135310 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.